Infectious Disease Clinics of North America volume 27, issue 1, P115-132 2013 DOI: 10.1016/j.idc.2012.11.004 View full text
|
|
Share
Jörg Ruhe, Donna Mildvan

Abstract: Community-acquired pneumonia (CAP) is a frequent cause of morbidity and mortality in the United States and worldwide, in particular among older patients and those with significant comorbid conditions. Current guidelines recommend therapy with a fluoroquinolone or a β-lactam plus a macrolide for the treatment of hospitalized adults with CAP who do not require admission to an intensive care unit. This article provides a brief summary and overview of the existing literature on this topic categorized by the main r…

expand abstract